FENC — FENNEC PHARMACEUTICALS INC

Ownership history in Stonepine Capital Management, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in FENNEC PHARMACEUTICALS INC (FENC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.28% (2025 Q4)
Avg. % of fund
0.28%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 50,000 — — 0.28% $385K $7.70
% of Fund (quarterly)    FENC price (monthly, adj. close)

Other funds also holding FENC

As of 2025 Q4 — sorted by position size

Solas Capital Management, LLC 3Y 7Y 11.19% Rosalind Advisors, Inc. 7.07% Lion Point Capital, LP 3Y 7Y 4.48% AIGH Capital Management LLC 3Y 2.95% AWM Investment Company, Inc. 3Y 7Y 0.53% Southpoint Capital Advisors LP 3Y 7Y 0.49% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.27% Hartford Financial Management Inc. 3Y 7Y 0.1% 1492 Capital Management LLC 3Y 7Y 0.08% GENDELL JEFFREY L 3Y 7Y 0.02%
← Back to Stonepine Capital Management, LLC Holdings